Sector • Healthcare Industry • Medical Laboratories |
Industry • Medical Laboratories |
Sector • Healthcare |
A loss of $-0.18 per Share at SLGC during the July to September 30 2022 time-frame
company announced third quarter of 2022 operating deficit of $-40.612 millions
Published Nov 16 2022
CSIMarket Team / CSIMarket.com
compared to the preceding financial reporting period advanced loss from $-0.13 per share and Revenue doubled by 194.917 % from $14.14 millions.
In the July to September 30 2022 time-frame Somalogic Inc reported net loss of $-32.942 million, instead of deficit of $-41.419 millions in the comparable financial reporting period a year ago.
Somalogic Inc is expected to report next financial earnings on May 15, 2023.
Other SLGC's news
Maximizing Stockholder Value: Unlocking the Future through Transformative Moves
Revitalizing Growth: Somalogic Inc Witnessed a Startling Plunge in Revenue Throughout Q3 2023
Somalogic Inc Reports $-0.13 Per Share Shortfall in Q2 2023
Massive $139 Million Loss Revealed ? Can They Turn It Around?
A loss of $-0.18 per Share at SLGC during the July to September 30 2022 time-frame
Other SLGC's news
Maximizing Stockholder Value: Unlocking the Future through Transformative Moves
Revitalizing Growth: Somalogic Inc Witnessed a Startling Plunge in Revenue Throughout Q3 2023
Somalogic Inc Reports $-0.13 Per Share Shortfall in Q2 2023
Massive $139 Million Loss Revealed ? Can They Turn It Around?
A loss of $-0.18 per Share at SLGC during the July to September 30 2022 time-frame